Akzo Nobel NV (NL:AKZA)
:AKZA
Want to see NL:AKZA full AI Analyst Report?
Top Page
Akzo Nobel NV
(AKZA)
Select Model
Select Model
Rating:65Neutral
Price Target:
€57.00
▲(4.78% Upside)
Action:ReiteratedDate:04/24/26
The score is driven primarily by solid profitability and improving free cash flow, plus very attractive valuation (low P/E with a ~3.75% dividend). These positives are tempered by declining revenue and elevated leverage, and the technical picture remains weaker longer-term despite short-term stabilization.
Positive Factors
Diversified Business Model
AkzoNobel's exposure across decorative and performance coatings and end markets like construction, automotive and marine provides durable demand diversification. Strong brands and global distribution reduce dependence on any single region or cyclical sector, supporting stable sales and pricing over time.
Negative Factors
Soft Revenue Trend
A continuing top-line decline constrains operating leverage and limits scope for margin expansion via volume growth. Persistent revenue weakness can signal market share pressure, slower end-market activity, or execution issues that materially impede sustainable earnings growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Business Model
AkzoNobel's exposure across decorative and performance coatings and end markets like construction, automotive and marine provides durable demand diversification. Strong brands and global distribution reduce dependence on any single region or cyclical sector, supporting stable sales and pricing over time.
Read all positive factors
Akzo Nobel NV (AKZA) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€8.95B
Dividend Yield3.38%
Average Volume (3M)372.10K
Price to Earnings (P/E)22.6
Beta (1Y)0.95
Revenue Growth-7.05%
EPS Growth32.41%
CountryNL
Employees34,100
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.89
Shares Outstanding171,041,670
10 Day Avg. Volume339,692
30 Day Avg. Volume372,104
Financial Highlights & Ratios
PEG Ratio0.94
Price to Book (P/B)2.17
Price to Sales (P/S)1.00
P/FCF Ratio16.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€58.63Price Target Upside7.77% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)3.86
Revenue Forecast (FY)€9.99B
Akzo Nobel NV Business Overview & Revenue Model
Company Description
Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry...
How the Company Makes Money
Akzo Nobel makes money primarily by selling paints and coatings products and related services to professional customers (such as industrial manufacturers, contractors, and shipyards), and to consumers primarily through retail channels for decorati...
Akzo Nobel NV Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
55
Neutral
Cash Flow
64
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.93B | 10.16B | 10.71B | 10.67B | 10.85B | 9.59B |
| Gross Profit | 3.98B | 4.05B | 4.34B | 4.23B | 3.92B | 3.85B |
| EBITDA | 1.59B | 1.54B | 1.40B | 1.41B | 1.05B | 1.53B |
| Net Income | 621.00M | 635.00M | 542.00M | 442.00M | 352.00M | 829.00M |
Balance Sheet | ||||||
| Total Assets | 15.49B | 13.95B | 14.25B | 14.56B | 14.74B | 13.88B |
| Cash, Cash Equivalents and Short-Term Investments | 3.03B | 1.92B | 1.47B | 1.78B | 1.79B | 1.21B |
| Total Debt | 6.11B | 4.86B | 5.37B | 5.56B | 5.88B | 3.55B |
| Total Liabilities | 10.43B | 9.13B | 9.43B | 10.01B | 10.19B | 8.24B |
| Stockholders Equity | 4.88B | 4.66B | 4.57B | 4.32B | 4.33B | 5.42B |
Cash Flow | ||||||
| Free Cash Flow | 660.00M | 606.00M | 362.00M | 834.00M | -29.00M | 317.00M |
| Operating Cash Flow | 956.00M | 915.00M | 741.00M | 1.21B | 291.00M | 605.00M |
| Investing Cash Flow | 482.00M | 424.00M | -132.00M | -144.00M | -1.09B | -134.00M |
| Financing Cash Flow | -235.00M | -964.00M | -684.00M | -827.00M | 1.14B | -974.00M |
Akzo Nobel NV Technical Analysis
Neutral
54.40
Price Trends
54.27
Positive
55.99
Negative
57.22
Negative
Market Momentum
-0.23
Negative
58.69
Neutral
82.87
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AKZA, the sentiment is Neutral. The current price of 54.4 is above the 20-day moving average (MA) of 50.18, above the 50-day MA of 54.27, and below the 200-day MA of 57.22, indicating a neutral trend. The MACD of -0.23 indicates Negative momentum. The RSI at 58.69 is Neutral, neither overbought nor oversold. The STOCH value of 82.87 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NL:AKZA.
Akzo Nobel NV Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | €8.95B | 22.64 | 14.61% | 3.38% | -7.05% | 32.41% | |
64 Neutral | €5.69B | 20.99 | 10.83% | 2.83% | 1.08% | -24.24% | |
59 Neutral | €1.06B | 14.40 | 8.84% | 3.50% | -1.61% | 38.58% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | €2.90B | 21.98 | -0.24% | 5.41% | -2.80% | -96.11% | |
52 Neutral | €15.42B | -2.82 | ― | 3.61% | -29.42% | -564.23% | |
49 Neutral | €1.14B | -5.46 | 6.84% | 1.46% | 13.55% | 50.22% |
* General Sector Average
NL:AKZA
Akzo Nobel NV
52.30
-1.78
-3.30%
NL:AMG
AMG ADVANCED METALLURGICAL GROUP NV
35.18
19.69
127.17%
NL:APAM
Aperam S.A.
40.78
14.92
57.70%
NL:CRBN
Corbion NV
18.49
0.46
2.55%
NL:IMCD
IMCD N.V.
96.38
-18.47
-16.08%
NL:DSFIR
DSM-Firmenich AG
64.40
-26.25
-28.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.